Please Wait
Applying Filters...
Xls
2D Structure
Also known as: 1219707-39-7, Lcb01-0371, Lcb-01-0371, Lcb-010371, 43ep6xv33e, (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
Molecular Formula
C14H17FN4O3
Molecular Weight
308.31  g/mol
InChI Key
QLUWQAFDTNAYPN-LLVKDONJSA-N
FDA UNII
43EP6XV33E

Lcb01 0371 is under investigation in clinical trial NCT01554995 (A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study).
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(5R)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
2.1.2 InChI
InChI=1S/C14H17FN4O3/c1-17-4-5-18(9-16-17)13-3-2-10(6-12(13)15)19-7-11(8-20)22-14(19)21/h2-3,6,9,11,20H,4-5,7-8H2,1H3/t11-/m1/s1
2.1.3 InChI Key
QLUWQAFDTNAYPN-LLVKDONJSA-N
2.1.4 Canonical SMILES
CN1CCN(C=N1)C2=C(C=C(C=C2)N3CC(OC3=O)CO)F
2.1.5 Isomeric SMILES
CN1CCN(C=N1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CO)F
2.2 Other Identifiers
2.2.1 UNII
43EP6XV33E
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Lcb01-0371

2.3.2 Depositor-Supplied Synonyms

1. 1219707-39-7

2. Lcb01-0371

3. Lcb-01-0371

4. Lcb-010371

5. 43ep6xv33e

6. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one

7. (5r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(hydroxymethyl)-1,3-oxazolidin-2-one

8. (5r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one

9. (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one

10. 2-oxazolidinone, 3-(4-(5,6-dihydro-1-methyl-1,2,4-triazin-4(1h)-yl)-3-fluorophenyl)-5-(hydroxymethyl)-, (5r)-

11. Unii-43ep6xv33e

12. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one

13. (5r)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)oxazolidin-2-one

14. Delpazolid [inn]

15. Delpazolid [who-dd]

16. Delpazolid (lcb01-0371)

17. Chembl1673408

18. Schembl11969210

19. Gtpl10999

20. Bcp25650

21. Ex-a1715

22. Db13077

23. Lcb-01,0371

24. Ac-33876

25. Hy-100180

26. Cs-0018175

27. Q27258646

2.4 Create Date
2009-09-28
3 Chemical and Physical Properties
Molecular Weight 308.31 g/mol
Molecular Formula C14H17FN4O3
XLogP30.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass308.12846858 g/mol
Monoisotopic Mass308.12846858 g/mol
Topological Polar Surface Area68.6 Ų
Heavy Atom Count22
Formal Charge0
Complexity450
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Protein Synthesis Inhibitors

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)